Device to Spot Alzheimer’s Onset in Adults Recognized by FDA

Device to Spot Alzheimer’s Onset in Adults Recognized by FDA

303106

Device to Spot Alzheimer’s Onset in Adults Recognized by FDA

Altoida’s artificial intelligence (AI)-powered device, intended to indicate the start of Alzheimer’s disease in adults with mild dementia but no evident disease symptoms, has been designated a breakthrough device by the U.S. Food and Drug Administration (FDA). The non-invasive device uses a software that measures and monitors neurocognitive function to diagnose and distinguish Alzheimer’s disease from other disorders. These include mild cognitive impairment (MCI), a neurological disorder marked by subtle changes in memory and considered a risk…

You must be logged in to read/download the full post.